The first 2 authors contributed equally to this article.
Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer
Version of Record online: 10 JUN 2014
© 2014 American Cancer Society
Volume 120, Issue 18, pages 2876–2882, September 15, 2014
How to Cite
Salami, S. S., Vira, M. A., Turkbey, B., Fakhoury, M., Yaskiv, O., Villani, R., Ben-Levi, E. and Rastinehad, A. R. (2014), Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer. Cancer, 120: 2876–2882. doi: 10.1002/cncr.28790
See editorial on pages 2806–9, this issue.
- Issue online: 4 SEP 2014
- Version of Record online: 10 JUN 2014
- Manuscript Accepted: 3 MAR 2014
- Manuscript Revised: 27 FEB 2014
- Manuscript Received: 31 JAN 2014
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.